Royal DSM N.V. today provides the investment community withcomparative figures for 2007 that reflect the company's new clusterstructure as of 1 January 2008. The new structure was announced inSeptember 2007 and is a result of the acceleration of DSM's strategyVision 2010 - Building on Strengths.

As of 1 January 2008 DSM's activities are grouped into five reportingclusters to reflect DSM's accelerated shift to Life Sciences andMaterials Sciences: Nutrition, Pharma, Performance Materials andPolymer Intermediates as well as the non-core Base Chemicals andMaterials cluster.

The comparative figures can be found in the annex to this pressrelease and can also be downloaded from the Investors section on theDSM corporate website, www.dsm.com.

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates innovative products and services in LifeSciences and Materials Sciences that contribute to the quality oflife. DSM's products and services are used globally in a wide rangeof markets and applications, supporting a healthier, more sustainableand more enjoyable way of life. End markets include human and animalnutrition and health, personal care, pharmaceuticals, automotive,coatings and paint, electrics and electronics, life protection andhousing. DSM has annual sales of almost EUR 8.8 billion and employssome 23,000 people worldwide. The company is headquartered in theNetherlands, with locations on five continents. DSM is listed onEuronext Amsterdam. More information: www.dsm.com.



For more information:DSM Corporate Communications DSM Investor RelationsElvira Luykx Hans Vossentel. +31 (0) 45 tel. +31 (0) 45 57828645782035 fax +31 (0) 45 5782595fax +31 (0) 45 e-mail5740680 investor.relations@dsm.come-mail media.relations@dsm.com

Copyright © Hugin AS 2008. All rights reserved.